Carolina Jerez
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
TMBIM6 enhances dopaminergic neuron survival by modulating the IRE1a pathway in Parkinson's disease.
TMBIM6 enhances dopaminergic neuron survival by modulating the IRE1a pathway in Parkinson's disease.
Journal: Cell death & disease
Published: April 30, 2025
IGF2-Reprogrammed Macrophages Ameliorate the Inflammatory Response and Protect Against the Neuroinflammatory Process in Parkinson's Disease Models.
Journal: Aging cell
Published: June 24, 2024
IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson's disease models.
Journal: Cell death discovery
Published: September 06, 2023
The c-Abl/p73 pathway induces neurodegeneration in a Parkinson's disease model.
Journal: IBRO neuroscience reports
Published: January 31, 2022
Enforced dimerization between XBP1s and ATF6f enhances the protective effects of the UPR in models of neurodegeneration.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 09, 2020
Inhibition of the 3-hydroxy-3-methyl-glutaryl-CoA reductase induces orofacial defects in zebrafish.
Journal: Birth defects research. Part A, Clinical and molecular teratology
Published: May 04, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026